We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.26%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.8B
AUM Growth
-$159M
Cap. Flow
-$187M
Cap. Flow %
-3.89%
Top 10 Hldgs %
18.32%
Holding
695
New
64
Increased
242
Reduced
263
Closed
62

Top Sells

Rank Stock Value
1
EWJ icon
iShares MSCI Japan ETF
EWJ
+$40.8M
2
INTU icon
Intuit
INTU
+$32.8M
3
META icon
Meta Platforms (Facebook)
META
+$30.3M
4
MA icon
Mastercard
MA
+$28.3M
5
NKE icon
Nike
NKE
+$25.9M

Sector Composition

Rank Sector Weight
1 Healthcare 29.43%
2 Financials 13.37%
3 Technology 9.86%
4 Consumer Discretionary 7.77%
5 Industrials 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
1
Amgen
AMGN
$197B
$134M 2.78%
871,649
+76,688
+10% +$12.3M
GILD icon
2
Gilead Sciences
GILD
$165B
$126M 2.63%
1,078,973
+126,083
+13% +$13.8M
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.29T
$109M 2.27%
4,117,680
+1,261,781
+44% +$33.8M
JNJ icon
4
Johnson & Johnson
JNJ
$599B
$95.6M 1.99%
981,385
+18,573
+2% +$1.86M
AAPL icon
5
Apple
AAPL
$4.8T
$87.9M 1.83%
2,802,788
-184,176
-6% -$5.89M
BIIB icon
6
Biogen
BIIB
$29.5B
$82.1M 1.71%
203,206
+13,923
+7% +$5.59M
CELG
7
DELISTED
Celgene Corp
CELG
$70.3M 1.46%
607,182
-104,196
-15% -$11.9M
REGN icon
8
Regeneron Pharmaceuticals
REGN
$70.5B
$62.4M 1.3%
122,353
+3,100
+3% +$1.51M
QCOM icon
9
Qualcomm
QCOM
$180B
$61.4M 1.28%
981,033
+193,208
+25% +$13.2M
XOM icon
10
ExxonMobil
XOM
$615B
$51M 1.06%
612,432
-14,756
-2% -$1.27M
PFE icon
11
Pfizer
PFE
$141B
$50.5M 1.05%
1,586,178
+401,253
+34% +$13.1M
EMC
12
DELISTED
EMC CORPORATION
EMC
$46.3M 0.96%
1,756,292
+1,223,665
+230% +$32.6M
V icon
13
Visa
V
$686B
$46.1M 0.96%
686,476
-200,277
-23% -$13.6M
MRK icon
14
Merck
MRK
$307B
$45.3M 0.94%
834,624
-68,050
-8% -$3.82M
MSFT icon
15
Microsoft
MSFT
$2.99T
$44.5M 0.93%
1,008,269
+311,435
+45% +$14.2M
PEP icon
16
PepsiCo
PEP
$185B
$41.8M 0.87%
448,142
+18,835
+4% +$1.8M
VZ icon
17
Verizon
VZ
$182B
$40.7M 0.85%
872,113
+22,619
+3% +$1.11M
CL icon
18
Colgate-Palmolive
CL
$73.6B
$39.5M 0.82%
604,233
+81,492
+16% +$5.53M
SNI
19
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$38.3M 0.8%
586,625
+456,164
+350% +$31.1M
KEY icon
20
KeyCorp
KEY
$25.2B
$36.8M 0.77%
2,453,048
-19,364
-0.8% -$285K
T icon
21
AT&T
T
$153B
$36.6M 0.76%
1,363,717
-154,543
-10% -$3.99M
ABBV icon
22
AbbVie
ABBV
$448B
$36M 0.75%
536,135
+70,584
+15% +$4.61M
IYR icon
23
iShares US Real Estate ETF
IYR
$4.53B
$35.8M 0.75%
502,075
+431,494
+611% +$32.7M
ALXN
24
DELISTED
Alexion Pharmaceuticals
ALXN
$34.2M 0.71%
189,027
-10,930
-5% -$1.89M
ROK icon
25
Rockwell Automation
ROK
$51B
$33.4M 0.69%
267,668
-63,981
-19% -$7.71M

Similar funds

Candriam SCA's Q2 2015 Portfolio in Review

As of Q2 2015, Candriam SCA held 695 positions worth $4.8B, down 3.2% from $4.96B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA withdrew a net $187M in Q2 2015, closing 62 positions and reducing 263 holdings. Its most notable exit was iShares MSCI Japan ETF, an estimated $40.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 28% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in American Airlines Group worth $11.6M.

  • Candriam SCA's largest Q2 2015 buy was American Airlines Group: 290,014 shares worth $11.6M.
  • Candriam SCA added most to Alphabet (Google) Class C in Q2 2015, an estimated $33.8M increase.
  • Candriam SCA's biggest Q2 2015 reduction was Intuit, cutting an estimated $32.8M.
  • Candriam SCA fully exited iShares MSCI Japan ETF in Q2 2015, selling an estimated $40.8M.
  • Candriam SCA's ten largest holdings make up 18% of its $4.8B portfolio in Q2 2015.
  • Candriam SCA opened 64 new positions and closed 62 in Q2 2015.
  • Candriam SCA's portfolio value fell 3.2% quarter-over-quarter to $4.8B.

Based on Candriam SCA's 13F filing for Q2 2015, filed 29 Jul 2015.